DOCSLIB.ORG

Manufacturers with Signed Rebate Agreements February 1 , 2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Manufacturers with Signed Rebate Agreements February 1 , 2011 Wisconsin Medicaid Pharmacy Data Table Manufacturers with Signed Rebate Agreements February 1 , 2011 NEWLABELER NAME START END SC NEW LABELER NAME START END SC 00002 ELI LILLY AND COMPANY 1/1/1991 Y 00126 COLGATE ORAL PHARMACEUTICAL 1/1/1991 Y 00003 E R SQUIBB AND SONS INC. 1/1/1991 Y 00131 SCHWARZ PHARMA, INC. 1/1/1991 Y 00004 HOFFMANN LAROCHE INC 1/1/1991 00132 C B FLEET COMPANY INC. 1/1/1991 00005 LEDERLE LABORATORIES 1/1/1991 Y 00135 SMITHKLINE BEECHAM 1/1/1995 Y 00006 MERCK SHARP & DOHME 1/1/1991 Y 00143 WEST-WARD PHARMACEUTICAL C 1/1/1991 Y 00007 SMITHKLINE BEECHAM CORPORATI 1/1/1991 Y 00145 STIEFEL LABORATORIES INC. 1/1/1991 Y 00008 WYETH AYERST LABORATORIES 1/1/1991 Y 00149 PROCTER & GAMBLE PHARMACEU 1/1/1991 Y 00009 PHARMACIA AND UPJOHN 1/1/1991 Y 00168 E FOUGERA AND CO, DIV OF ALTAN 1/1/1991 Y 00013 PHARMACIA AND UPJOHN 1/1/1991 Y 00169 NOVO NORDISK PHARMACEUTICAL 1/1/1991 Y 00015 INVAMED, INC 1/1/1991 Y 00172 ZENITH LABORATORIES, INC 1/1/1991 Y 00023 ALLERGAN INC. 1/1/1991 Y 00173 GLAXOSMITHKLINE 1/1/1991 Y 00024 SANOFI SYNTHELABO 1/1/1991 Y 00178 MISSION PHARMACAL COMPANY 1/1/1991 Y 00025 PHARMACIA CORPORATION 1/1/1991 Y 00182 GOLDLINE LABORATORIES INC 1/1/1991 Y 00026 BAYER CORP PHARMACEUTICAL DI 1/1/1991 Y 00185 EON LABS MANUFACTURING, INC. 1/1/1991 Y 00028 NOVARTIS PHARMACEUTICALS 1/1/1991 Y 00186 ASTRAZENECA LP 1/1/1991 Y 00029 SMITHKLINE BEECHAM CORPORATI 1/1/1991 Y 00187 ICN PHARMACEUTICALS INC. 1/1/1991 Y 00031 LEDERLE PIPERACILLIN 1/1/1991 Y 00206 ELKINS-SINN 1/1/1991 Y 00032 INTERNATIONAL LABORATORIES 1/1/1991 Y 00212 SANDOZ NUTRITION 1/1/1991 00037 CARTER- WALLACE, INC. 1/1/1991 Y 00224 KONSYL PHARMACEUTICALS, INC. 1/1/1992 00039 HOECHST MARION ROUSSEL INC. 1/1/1991 Y 00225 B F ASHER COMPANY INC., 1/1/1991 00045 MCNEIL PHARMACEUTICAL 1/1/1991 Y 00228 PUREPAC PHARM. CO, DIV KALIPHA 1/1/1991 Y 00046 LEDERLE PARENTERALS 1/1/1991 Y 00245 UPSHER-SMITH LABORATORIES IN 1/1/1991 Y 00049 PFIZER-ROERIG 1/1/1991 Y 00256 FLEMING AND COMPANY 10/1/1991 Y 00051 UNIMED PHARMACEUTICALS, INC 10/1/1997 Y 00258 INWOOD LABORATORIES INC 1/1/1991 Y 00052 ORGANON INC. 1/1/1991 00259 MERZ PHARMACEUTICALS 1/1/1991 00053 AVENTIS BEHRING 1/1/1991 00264 B BRAUN MEDICAL, INC. 1/1/1991 00054 ROXANE LABORATORIES, INC. 1/1/1991 Y 00276 MISEMER PHARMACEUTICAL, INC. 10/1/2006 00056 DU PONT PHARMACEUTICALS 1/1/1991 Y 00277 LASER INC 1/1/1991 Y 00062 ORTHO MCNEIL PHARMACEUTICAL 1/1/1991 Y 00281 SAVAGE LABS, DIV OF ALTANA INC 1/1/1991 Y 00064 HEALTHPOINT LTD 7/1/1995 Y 00288 FLUORITAB CORPORATION 10/1/1991 00065 ALCON LABORATORIES, INC. 1/1/1991 Y 00299 GALDERMA, L.T. 1/1/1991 00066 DERMIK LABORATORIES 1/1/1991 Y 00300 TAP PHARMACEUTICALS INC 1/1/1991 Y 00067 NOVARTIS CONSUMER HEALTH INC 1/1/1991 00310 ASTRAZENECA LP 1/1/1991 Y 00068 HOECHST MARION ROUSSEL INC. 1/1/1991 Y 00327 UNITED GUARDIAN, INC. 1/1/1991 Y 00069 PFIZER INC 1/1/1991 Y 00338 BAXTER HEALTHCARE CORPORATI 1/1/1991 00071 WARNER-LAMBERT 1/1/1991 Y 00378 MYLAN PHARMACEUTICALS, INC. 1/1/1991 Y 00072 APOTHECON INC 1/1/1991 00406 MALLINCKRODT SPECIALTY CHEMI 7/1/1993 Y 00074 ABBOTT LABORATORIES 1/1/1991 Y 00409 HOSPIRA, INC 1/1/2005 00075 RHONE-POULENC RORER PHARMA 1/1/1991 Y 00414 SUPPOSITORIA LABORATORIES 4/1/1994 Y 00078 NOVARTIS PHARMACEUTICALS 1/1/1991 Y 00430 WARNER CHILCOTT LABORATORIE 1/1/1998 00083 NOVARTIS PHARMACEUTICALS 1/1/1991 Y 00456 FOREST PHARMACEUTICALS INC 1/1/1991 Y 00085 SCHERING PLOUGH PHARMACEUTI 1/1/1991 00462 PHARMADERM 7/1/2003 00087 BRISTOL-MYERS SQUIBB COMPANY 1/1/1991 Y 00469 LYPHOMED DIVISION FUJISAWA US 1/1/1991 Y 00088 HOECHST MARION ROUSSEL, INC. 1/1/1991 Y 00472 ALPHARMA, USPD 1/1/1991 Y 00089 3M PHARMACEUTICALS 1/1/1991 Y 00482 BRADLEY PHARMACEUTICALS, INC. 1/1/1991 Y 00091 KREMERS URBAN CO. 1/1/1991 Y 00485 EDWARDS PHARMACEUTICALS, IN 1/1/1991 Y 00093 TEVA PHARMACEUTICALS 1/1/1991 Y 00486 BEACH PRODUCTS INC 1/1/1991 Y 00095 ECR PHARMACEUTICALS 7/1/1993 Y 00487 NEPHRON PHARMACEUTICALS CO 4/1/1992 Y 00096 PERSON & COVEY INC. 4/1/1999 00496 FERNDALE LABORATORIES INC. 1/1/1991 Y 00113 L. PERRIGO COMPANY 7/1/2003 00517 AMERICAN REGENT LABS, INC. 7/1/1993 00115 GLOBAL PHARMACEUTICAL COMPA 1/1/1991 Y 00525 PAN AMERICAN LABORATORIES IN 1/1/1991 Y 00116 XTTRIUM LABORATORIES, INC 1/1/2002 Y 00527 LANNETT COMPANY INC. 7/1/1994 Y 00121 PHARMACEUTICAL ASSOCIATES, IN 1/1/1991 Y 00535 GILBERT LABORATORIES 7/1/2002 Y Page 1 of 6 N = NEW; D = DELETED; X = COVERED (NO REBATE AGREEMENT); Y=SENIORCARE REBATE AGREEMENT ON FILE Wisconsin Medicaid Pharmacy Data Table Manufacturers with Signed Rebate Agreements February 1 , 2011 NEWLABELER NAME START END SC NEW LABELER NAME START END SC 00536 WATSON PHARMA, INC 1/1/1991 Y 11523 SCHERING PLOUGH HEALTHCARE 4/1/2003 00548 INTERNATIONAL MEDICATION SYS 1/1/1991 Y 11528 CENTRIX PHARMACEUTICAL, INC 7/1/2006 Y 00555 BARR LABORATORIES INC 1/1/1991 Y 11530 GLAXOSMITHKLINE 4/1/2002 Y 00573 WYETH AYERST LABORATORIES 1/1/1991 11701 COLOPLAST CORPORATION 10/1/1991 Y 00574 PADDOCK LABORATORIES, INC. 1/1/1991 Y 11980 ALLERGAN INC 1/1/1991 Y 00575 BAKER NORTON PHARMACEUTICAL 1/1/1991 Y 11994 BERLEX LABORATORIES 10/6/2010 00590 DU PONT PHARMACEUTICALS 1/1/1991 Y 12496 RECKITT & COLMAN PHARMACEUTI 1/1/1994 00591 WATSON PHARMA, INC 7/1/2001 Y 12593 RED RIIVER PHARMA MANUFACTUR 4/1/2006 00597 BOEHRINGER INGELHEIM PHARMA 1/1/1991 Y 12830 R.A. MCNEIL 1/1/1991 Y 00603 QUALITEST PRODUCTS, INC. 1/1/1991 Y 12939 MARLOP PHARMACEUTICALS, INC. 1/1/1991 00615 VANGUARD LABS, INC 1/1/1991 Y 12948 NITROMED INC 10/1/2005 00641 ESI LEDERLE, INC 1/1/1991 13107 AUROBINDO PHARMA USA, INC 7/1/2005 Y 00642 EVERETT LABORATORIES 1/1/1991 Y 13279 ALLAN PHARMACEUTICALS, LLC 10/1/2005 00677 UNITED RESEARCH LABORATORIE 1/1/1991 Y 13310 A R SCIENTIFIC, INC 1/1/2006 Y 00682 MARNEL PHARMACEUTICALS INC 1/1/1991 13436 VENUS 1/1/2009 00703 GENSIA SICOR PHARMACEUTICALS 7/1/1992 Y 13453 GRACEWAY PHARMACEUTICALS, L 4/1/2007 Y 00713 G AND W LABORATORIES INC 1/1/1991 Y 13478 BARRIER THERAPEUTICS 1/1/2006 00777 DISTA PRODS CO DIV OF ELI LILLY 1/1/1991 Y 13533 TALECRIS BIOTHERAPEUTICS, INC 10/1/2005 00781 GENEVA PHARMACEUTICALS, INC., 1/1/1991 Y 13548 CORIA LABORATORIES, LTD 4/1/2006 00785 UAD LABORATORIES INC 1/1/1991 Y 13551 FSC LABORATORIES, INC 1/1/2006 00813 PHARMICS INC. 1/1/1991 D 13632 ROSEMONT PHARMACEUTICALS LT 7/1/2007 3/31/2011 00832 USL PHARMA, INC 1/1/1991 Y 13668 TORRENT PHARM, INC. 10/1/2007 Y 00884 PEDINOL PHARMACAL INC 1/1/1991 13811 TRIGEN LABORATORIES, INC. 4/1/2006 00904 MAJOR PHARMACEUTICALS 1/1/1991 Y 13845 DBA THE CHAO CENTER 4/30/2009 00941 BAXTER HEALTHCARE CORP. 4/1/2010 13913 DEPOMED, INC 10/1/2005 00944 BAXTER BIOTECH 1/1/1991 13925 SETON PHARMACEUTICALS, LLC 11/18/2008 00955 SANOFI SYNTHELABO 1/1/1996 14168 STONEBRIDGE PHARMA , LLC 1/1/2007 Y 00998 ALCON -PUERTO RICO- INC. 1/1/1991 Y 14508 SUN PHARMACEUTICAL INDUSTRIE 7/1/2006 Y 08880 KENDALL HEALTHCARE PRODUCTS 1/1/1991 14550 ACTAVIS PHARMA MFGING PRIVAT 4/27/2010 Y 08884 SHERWOOD MEDICAL 1/1/1991 15054 TERCICA, INC 4/1/2006 10019 BAXTER HEALTHCARE CORPORATI 10/1/2001 15127 SELECT BRAND DISTRIBUTORS 10/1/2006 10122 CORNERSTONE BIOPHARM, INC 7/1/2005 D 15210 OTN GENERICS, INC. 10/1/2006 3/31/2011 10139 GENERALMEDIX, INC. 12/9/2008 15330 GENPHARM, L.P. 4/1/2006 Y 10144 ACORDA THERAPEUTICS, INC 10/1/2005 15338 APACE KY, LLC 1/1/2009 Y 10147 PATRIOT PHARMACEUTICALS, LLC 4/1/2005 Y 15370 CARWIN ASSOCIATES, INC. 10/1/2006 Y 10148 COTHERIX, INC 7/1/2005 15456 ESPRIT PHARMA, INC. 4/1/2006 Y 10158 GLAXOSMITHKLINE 4/1/2002 Y 15584 BRISTOL-MYERS SQUIBB & GILEAD 7/1/2006 Y 10267 CONTRACT PHARMACAL CORP 1/1/1991 Y 15686 MIDLAND HEALTHCARE, LLC 4/1/2006 10337 DOAK DERMATOLOGICS DIV 7/1/2002 Y 15821 FOCUS LABORATORIES, INC. 10/1/2006 10370 ANCHEN PHARMACEUTICALSINC 7/1/2007 16103 PHARBEST PHARMACEUTICALS, IN 10/1/2006 10454 SOLSTICE NEUROSCIENCES, INC 1/1/2006 16252 COBALT LABORATORIES, INC 10/1/2006 Y 10542 HILLESTAD INTERNATIONAL, INC. 4/1/1994 Y 16477 LASER PHARMACEUTICALS, LLC 7/1/2006 Y 10572 AFFORDABLE PHARMACEUTICALS, 1/1/2005 Y 16571 PACK PHARMACEUTICALS, L.L.C. 4/1/2006 Y 10631 RANBAXY LABORATORIES INCORP 10/1/2005 16714 NORTHSTAR RX, LLC 4/1/2008 Y 10702 KVK TECH INC 1/1/2007 Y 16729 ACCORD HEALTHCARE INC. 7/1/2008 Y 10768 PERRIGO PHARMACEUTICALS CO 4/1/2005 16781 ONSET THERAPEUTICS 7/1/2006 10892 LUNSCO INC 1/1/1991 Y 16887 VERNALIS PHARMACEUTICALS INC 10/1/2006 10914 BRIGHTON PHARMACEUTICALS, IN 1/1/2006 17314 ALZA CORPORATION 1/1/1991 Y 10922 INTENDIS, INC 10/1/2005 17433 ENEMEEZ INC 4/1/2007 Y 11042 ADVANCIS PHARMACEUTICAL 1/1/2006 17478 AKORN INC 1/1/1991 Y 11098 AKORN MANUFACTURING 1/1/1996 Y 18011 ZERIS PHARMA, LLC.
Load more

Recommended publications
  • Chrysler Affiliate Rewards Program
    Chrysler Affiliate Rewards Program If you or your spouse work, or have retired from, one of the companies listed below, you may qualify for pricing as low as 1% Below Factory Invoice on a New FIAT! Check the list of companies below to see if your company qualifies.* A F O AAA-- State of Ohio Members Freightliner Of Tampa, Llc Ocala Freightliner ABB, Inc. Freightliner Of Toledo OCE'- North America Abbott Labs Freightliner Of Utah, Llc Ocean Freightliner, Ltd. Abbott, Nicholson, Quilter, Freightliner Trucks So. Florida Inc. O'connor Gmc, Inc. Esshaki & Youngblood PC Freightliner Twin Ports O'connor Truck Sales, Inc. Abercrombie & Fitch Freightmasters Ohio Machinery Company AboveNet Fresenius Medical dba Ohio CAT Abraxis Bioscience Inc. Fresno Truck Center Oklahoma City Freightliner Accor North America FRIENDLY MOTORCARS Oklahoma Farm Bureau Ace Hardware Corporation Fru-Con Construction Corporation Oklahoma Publishing Company, Action Western Star Fujisawa Healthcare Inc. The (OPUBCO) Actelion Pharmaceuticals US, Inc. Ftl And Ws Of Maine Old Dominion Freight Lines Action Couriers Ftl And Wst Of Tifton Oldcastle Inc. ADVANTAGE Health Solutions, Inc. Ftl Stl Wst Of Odessa Omaha Truck Center Inc Advance Publications Ftl Trucks Of South Florida Omni Care Health Plan Aearo Company Ftl, Stl And Wst Of Montgomery One Call Locators Aetna Ftl,Stl, and Western Star Of Dothan One Source Management Inc Affinia Group Fyda Freightliner Cincinnati Oracle Corporation Agar Truck Sales, Inc. Fyda Freightliner Columbus,Inc Organon Pharmaceuticals USA, Inc. AGCO Corporation Fyda Freightliner Pittsburgh Orlando Freightliner AGFA Corporation Fyda Freightliner Youngstown Orlando Freightliner South Aggreko, LLC ORRIN B HAYES, INC. Agricredit Acceptance LLC G Oscient Pharmaceuticals Agrilink Foods OSI Pharmaceuticals Gabrielli Ford Truck Sales AGSTAR Financial Services Otjen, Van Ert, Stangle, Lieb & Weir, S.C.
    [Show full text]
  • Reporter's Handbook
    2O14 RE POR TER’ S HANDBOOK for the biopharmaceutical research industry Member Companies 1 Research Associates 2 U.S. Health-Related Trade and Professional Organizations 3 Government Medical and Health Contacts 4 Voluntary Health Agencies 5 International Pharmaceutical Associations/Health Care Groups 6 Key Facts/About PhRMA 7 Company Products by Category 8 Member Companies 1 Member Companies Abbott Dept 383, AP6D 100 Abbott Park Road Abbott Park, IL 60064-3500 Phone: (847) 937-6100 Fax: (847) 937-1511 Website: www.abbott.com Melissa Brotz, Corporate Public Affairs Office: (847) 935-3456 E-Mail: [email protected] Kelly Morrison, Corporate Public Affairs, Science/Policy Office: (847) 937-3802 E-Mail: [email protected] Scott Stoffel, Corporate Public Affairs, Financial Office: (847) 936-9502 E-Mail: [email protected] Steve Chesterman, Medical Optics Office: (714) 247-8711 E-Mail: [email protected] Jonathon Hamilton, Vascular Devices 3200 Lakeside Drive, Suite 355 Santa Clara, CA 95054 Office: (408) 845-3491 E-Mail: [email protected] AbbVie 1 North Waukegan Road North Chicago, IL 60064 Phone: (847) 932-7900 Website: www.abbvie.com Gulden Mesara, Vice President, Global Commercial and Health Communications Office: (847) 938-2804 E-Mail: [email protected] Angela Sekston, Vice President, Leadership and Employee Communications Office: (847) 937-6636 E-Mail: [email protected] Morry Smulevitz, Head of U.S. Public Affairs Office: (847) 937-2152 E-Mail: [email protected] 1-1
    [Show full text]
  • Representative Healthcare and Life Sciences M&A Transactions
    Representative Healthcare and Life Sciences M&A Transactions • Medtronic plc. Representing Medtronic plc in its $458 million acquisition of Twelve, Inc., a developer of devices for the treatment of chronic cardiovascular diseases. • Shire plc. Representing Shire plc in its $30 billion acquisition of Baxalta Incorporated, a developer of products for the treatment of hematology and immunology worldwide. • Pfizer Inc. Representing Pfizer Inc. in its $130 million acquisition of GlaxoSmithKline plc, a UK-based pharmaceuticals company. • Pfizer Inc. Representing Pfizer Inc. in its $17 billion acquisition of Hospira Inc., a provider of injectable drugs and infusion technologies. • Wright Medical Group. Representing Wright Medical Group in its $3.3 billion merger of equals with Tornier N.V., a Netherlands-based medical device company. • Synageva BioPharma. Represented Synageva BioPharma in its $8 billion sale to Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. • Pfizer Inc. Represented Pfizer Inc. in its investment in AM-Pharma B.V., an Amsterdam-based biopharmaceutical company. • Becton, Dickinson & Company. Represented Becton, Dickinson & Company in its acquisition of CRISI Medical Systems, Inc., a medical device company, focuses on the development of drug-delivery systems. • Cubist Pharmaceuticals. Represented Cubist Pharmaceuticals in its $9 billion sale to Merck & Co. Inc., a provider of health care solutions worldwide. • Symmetry Medical. Represented Symmetry Medical Inc. In the sale of OEM Solutions business to Tecomet, a Genstar Capital portfolio company, for $450 million. As part of the deal, Symmetry, a publicly held medical device solutions provider, will also spin off and transfer to its shareholders ownership in a new company, Specialty Surgical Instruments.
    [Show full text]
  • Major Employers of Chemists in the Northeastern Section
    Major Employers of Chemists in the Northeastern Section by Don Rickter with valuable assistance from Karen Piper, Mike Filosa, Lee Johnson, Dorothy Phillips and others Eastern Massachusetts and New Hampshire are a hotbed of dynamic chemistry companies. Some are start-ups that will grow dramatically. There are dozens of companies in both states. Some will merge or be acquired or change their names. Each has a unique personality and spectrum of expertise. The following list is most of the employers of seven or more members of the American Chemical Society — as of the end of May 2010. A few of the larger employers, with more than 35 ACS chemists, are in ALL CAPS. The locations are in eastern Massachusetts — unless marked with NH for New Hampshire. Aerodyne Research BIOGEN IDEC Cubist Pharmaceuticals Billerica CAMBRIDGE Lexington www.aerodyne.com/ www.biogenidec.com/ www.cubist.com Alkermes Inc. Boston Scientific Corp. Dow Electronic Materials Waltham Natick Marlborough www.alkermes.com/ www.bostonscientific.com/ www.dow.com/ & home.bsci www.rohmhaas.com/ Alnylam Pharmaceuticals Broad Institute [rhymes DSM-Neoresins Cambridge with road] Cambridge Wilmington www.alnylam.com/ www.broadinstitute.org/ www.dsm.com/en_US/htm l/dnr/home. htm AMGEN INC. Bruker Corp. CAMBRIDGE Billerica www.bruker.com E-Ink Corp. www.amgen.com/ Cambridge www.e- Cabot Corp. ink.com Ariad Pharmaceuticals Billerica www.cabot- Cambridge corp.com EISAI RESEARCH www.ariad.com/ INSTITUTE Cambridge Isotope Labs ANDOVER Arqule Inc. Andover www.easai.com Woburn www.arqule.com/ www.isotope.com/ EMD Serono ASTRA ZENECA Concert Pharmaceuticals Rockland WALTHAM Lexington www.emdserono.com www.astrazeneca.com/ www.concertpharma.com Enanta Pharmaceuticals Microbia (Also see Physical Sciences Inc.
    [Show full text]
  • Oncology Pharmaceutical
    Quarterly Industry Update As of December 31, 2015 Industry: Oncology Pharmaceutical Industry Summary Cogent Valuation identified Oncology Pharmaceutical publicly traded companies, IPOs, and recent M&A transactions within the Oncology Pharmaceutical industry, which provides a basis for market and transaction pricing that can be used by your firm in estimating market sentiment and its impact on your firm's value. Over the last year since December 31, 2014, the median 52-week share price return of the Oncology Pharmaceutical industry was 5.0%. Between December 31, 2013 and December 31, 2015, the median EV/EBITDA multiple decreased from 15.6 to 13.2. However, the median price-to-earnings multiple increased from 21.5 to 23.0 over the same period. Comparable Public Company Key Statistics Median 52-Week Return5.0% Median EV/Revenue Multiple5.0x Median Price/Earnings Multiple 23.0x Median 3-Year CAGR Return26.7% Median EV/EBITDA Multiple13.2x Median EV/Gross CF Multiple 13.2x Comparable Public Company Market Price Returns As of December 31, 2015 YTD 3 Month 1 Year 2 Year 3 Year 5 Year 2015 2014 2013 2012 2011 Affimed N.V. 14.8% 15.4% 14.8% N/A N/A N/A 14.8% N/A N/A N/A N/A Ariad Pharmaceuticals Inc. -9.0% 7.0% -9.0% -4.3% -31.2% 4.2% -9.0% 0.7% -64.4% 56.6% 140.2% Bellicum Pharmaceuticals, Inc. -12.0% 39.5% -12.0% N/A N/A N/A -12.0% N/A N/A N/A N/A Calithera Biosciences, Inc.
    [Show full text]
  • ANTARES PHARMA, INC. 100 Princeton South, Suite 300 Ewing, New Jersey 08628 April 27, 2020 Dear Stockholder: You Are Cordially I
    ANTARES PHARMA, INC. 100 Princeton South, Suite 300 Ewing, New Jersey 08628 April 27, 2020 Dear Stockholder: You are cordially invited to attend the 2020 Annual Meeting of Stockholders of Antares Pharma, Inc. (the “Company”), to be held at 10:00 a.m., Eastern Time, on Thursday, June 11, 2020 virtually via the Internet at www.virtualshareholdermeeting.com/ATRS2020 (the “Annual Meeting”). For the first time, our annual meeting will be a “virtual meeting” of stockholders, which will be conducted exclusively via the Internet through a virtual web conference. There will not be a physical meeting location, and stockholders will not be able to attend the annual meeting in person. Instructions on how to participate in the Annual Meeting and demonstrate proof of stock ownership are posted at www.virtualshareholdermeeting.com/ATRS2020. This means that you can attend the annual meeting online, vote your shares electronically and submit questions during the online meeting by visiting the above-mentioned website. We believe that hosting a “virtual meeting” will enable greater stockholder attendance and participation from any location around the world. In addition, in response to continued public health concerns related to COVID-19 and group gatherings, we also believe holding a “virtual meeting” will help ensure the health and well-being of our stockholders and other meeting participants. The notice of the 2020 Annual Meeting of Stockholders and the proxy statement that appear on the following pages describe the matters scheduled to come before the meeting. In addition, certain members of our Board of Directors and management team, as well as representatives of KPMG LLP, our independent registered public accounting firm, will be available to answer appropriate questions.
    [Show full text]
  • Clinical Research Services
    Clinical Research Services Advancing the future of medicine through research. Who We Are Experience Clinical Research Services is a department within Clinical Research Services has been involved CHI St. Alexius Health in Bismarck, ND. We are fully in clinical research since 1987. Our professional dedicated to providing research support services staff has more than 180 years of combined to physicians within our region and the valued experience in clinical trials. We are committed patients they serve. to providing outstanding service to ensure the success of every project. CHI St. Alexius Health is a tertiary care facility affiliated with PrimeCare, a health group which Our involvement in inpatient and outpatient combines the most experienced, trusted, and phase II-IV clinical and device research studies has proven medical leaders in the area. PrimeCare is contributed substantially to the approval of new comprised of a network which includes more than drugs and treatments. You should carefully consider 190 physicians in private and institutional practice, both the benefits and the risks of participation including: CHI St. Alexius Health, Mid Dakota Clinic, before enrolling in a study. The Bone & Joint Center, and other affiliated area physicians. Many of these physicians are actively Previous clinical study trials: involved as investigators for clinical trials. • Oncology • Orthopaedic • Rheumatology • Diabetes Our clinical research team is committed to providing: • Neurology • Weight loss • Rapid study start-up • Cardiology • Pain • Pro-active patient enrollment • Urology • Men’s Health • Clean data submission • Gastroenterology • Women’s Health • Highly experienced principal • Infectious Disease • Medical Devices investigators • Pediatric • Initial training and continuing education for all support personnel Sponsors Patient Demographics Abbott Laboratories Characteristics of our patients include Acorda Therapeutics, Inc.
    [Show full text]
  • Pharmaceutical Company Contact Information (PDF)
    Pharmaceutical Company Contact Information - Rebate Filing - as of June 2018 Labeler Name Invoice Contact Phone Extension 00002 LILLY USA, LLC LISA NORTON (317) 276-2000 00003 ER SQUIBB AND SONS INC. LYNN LEWIS (609) 897-4731 00004 GENENTECH CONTRACT ADMINISTRATION (650) 866-2666 00005 LEDERLE LABORATORIES DAN MAGUIRE (484) 563-5097 00006 MERCK & CO., INC. DOUG BICKFORD (215) 652-0671 00007 SMITHKLINE BEECHAM DAVID BUCKLEY (215) 751-5690 00008 WYETH LABORATORIES JENNIFER WOOTEN (901) 215-1883 00009 PHARMACIA AND UPJOHN COMPANY/PFIZER JENNIFER WOOTEN (901) 215-1883 00013 PHARMACIA AND UPJOHN COMPANY NICHOLAS CHRISTODOULOU (336) 291-1053 00014 G. D. SEARLE & CO. CINDY MCDONALD (847) 581-5726 00015 MEAD JOHNSON AND COMPANY LYNN LEWIS (609) 897-4731 00016 PHARMACIA INC. BARBARA WINGET (908) 901-7254 00023 ALLERGAN INC SHOBHANA MINAWALA (714) 246-6205 00024 SANOFI WINTHROP PHARMACEUTICALS LAURIE DUNLAP, ADMIN., GOVT. OPERATIONS (212) 551-4198 00025 PHARMACIA CORPORATION NICHOLAS CHRISTODOULOU (336) 291-1053 00026 BAYER CORPORATION PHARMACEUTICAL DIV. LINDA WOLCHESKI (203) 812-6372 00028 NOVARTIS PHARMACEUTICALS (862) 778-8094 00029 SMITHKLINE BEECHAM DAVID BUCKLEY (215) 751-5690 00031 A. H. ROBINS COMPANY DAN MAGUIRE (610) 902-3222 00032 SOLVAY PHARMACEUTICALS STACEY LENOX (847) 937-3979 00033 SYNTEX LABORATORIES, INC. JANICE BRENNAN (973) 562-3494 00034 THE PURDUE FREDERICK COMPANY JUNE STOWE (203) 899-8035 00037 CARTER-WALLACE, INC. JAY R BRENNAN (609) 655-6163 00038 ASTRAZENECA LP DAVID WRIGHT (302) 886-2268 7820 00039 AVENTIS PHARMACEUTICALS (908) 981-7461 00043 NOVARTIS CONSUMER HEALTH, INC. EDWARD D. COLLINS (973) 781-6191 00044 KNOLL LABORATORIES DEBRA DEYOUNG (847) 937-4372 00045 MCNEIL PHARMACEUTICAL (908) 218-6777 00046 AYERST LABORATORIES (901) 215-1473 00047 WARNER CHILCOTT LABORATORIES LISA KAROLCHYK (973) 442-3262 00048 KNOLL PHARMACEUTICAL COMPANY DEBRA DEYOUNG (847) 937-4372 00049 ROERIG NICHOLAS CHRISTODOULOU (336) 291-1053 00051 UNIMED PHARMACEUTICALS, INC STACY LENOX (847) 937-3979 00052 ORGANON, USA, INC.
    [Show full text]
  • LG4690 Healthcare Life Scien
    Healthcare and Life Sciences Group MERGERS & ACQUISITIONS hrough decades of experience in many of the transactions that have Tdefi ned the healthcare and life sciences industry, Sullivan & Cromwell offers clients comprehensive legal expertise paired with a practical understanding of commercial realities. With a multidisciplinary and integrated global practice, we provide our healthcare and life sciences clients with leading edge transactional advice, expertise on intellectual property intensive matters and deep litigation experience that is critical to the successful execution and consummation of deals and the resolution of disputes. As the following pages demonstrate, Sullivan & Cromwell’s Healthcare and Life Sciences Group has had the privilege of working on a number of transactions that have transformed the healthcare industry. We are grateful that our clients have trusted us with many of the industry’s most signifi cant matters. We look forward to working with existing and new clients and bringing to bear our industry expertise and experience in what promises to be another exciting year in dealmaking as companies continue to position themselves strategically in an ever-evolving industry. 1 Timeline of S&C’s Headline Healthcare and Google Life Sciences S&C client Google Life Life Sciences Transactions Sciences (U.S.) announces Royal Philips its formation as the fi rst of S&C client Royal Philips Baker Bros. Advisors the Alphabet companies, (Netherlands) completes S&C client Baker Bros. Advisors (U.S.) announces their funds role Bayer Verily
    [Show full text]
  • Rebateable Manufacturers
    Rebateable Labelers – July 2021 Manufacturers are responsible for updating their eligible drugs and pricing with CMS. Montana Healthcare Programs will not pay for an NDC not updated with CMS. Note: Some manufacturers on this list may have some NDCs that are covered and others that are not. Manufacturer ID Manufacturer Name 00002 ELI LILLY AND COMPANY 00003 E.R. SQUIBB & SONS, LLC. 00004 HOFFMANN-LA ROCHE 00006 MERCK & CO., INC. 00007 GLAXOSMITHKLINE 00008 WYETH PHARMACEUTICALS LLC, 00009 PHARMACIA AND UPJOHN COMPANY LLC 00013 PFIZER LABORATORIES DIV PFIZER INC 00015 MEAD JOHNSON AND COMPANY 00023 ALLERGAN INC 00024 SANOFI-AVENTIS, US LLC 00025 PFIZER LABORATORIES DIV PFIZER INC 00026 BAYER HEALTHCARE LLC 00032 ABBVIE INC. 00037 MEDA PHARMACEUTICALS, INC. 00039 SANOFI-AVENTIS, US LLC 00046 WYETH PHARMACEUTICALS INC. 00049 ROERIG 00051 ABBVIE INC 00052 ORGANON USA INC. 00053 CSL BEHRING L.L.C. 00054 HIKMA PHARMACEUTICAL USA, INC. 00056 BRISTOL-MYERS SQUIBB PHARMA CO. 00065 ALCON LABORATORIES, INC. 00068 AVENTIS PHARMACEUTICALS 00069 PFIZER LABORATORIES DIV PFIZER INC 00071 PARKE-DAVIS DIV OF PFIZER 00074 ABBVIE INC 00075 AVENTIS PHARMACEUTICALS, INC. 00078 NOVARTIS 00085 SCHERING CORPORATION 00087 BRISTOL-MYERS SQUIBB COMPANY 00088 AVENTIS PHARMACEUTICALS 00093 TEVA PHARMACEUTICALS USA, INC. 00095 BAUSCH HEALTH US, LLC Page 1 of 19 Manufacturer ID Manufacturer Name 00096 PERSON & COVEY, INC. 00113 L. PERRIGO COMPANY 00115 IMPAX GENERICS 00116 XTTRIUM LABORATORIES, INC. 00121 PHARMACEUTICAL ASSOCIATES, INC. 00131 UCB, INC. 00132 C B FLEET COMPANY INC 00143 HIKMA PHARMACEUTICAL USA, INC. 00145 STIEFEL LABORATORIES, INC, 00168 E FOUGERA AND CO. 00169 NOVO NORDISK, INC. 00172 TEVA PHARMACEUTICALS USA, INC 00173 GLAXOSMITHKLINE 00178 MISSION PHARMACAL COMPANY 00185 EON LABS, INC.
    [Show full text]
  • United States Securities and Exchange Commission Washington, D.C
    Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-33500 JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY (Exact name of registrant as specified in its charter) Ireland 98-1032470 (State or other jurisdiction of (I.R.S. Employer Identification incorporation or organization) No.) Fifth Floor, Waterloo Exchange Waterloo Road, Dublin 4, Ireland 011-353-1-634-7800 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on Title of each class which registered Ordinary shares, nominal The NASDAQ Stock Market value $0.0001 per share LLC Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Message from the President
    DermNewsletter of the American OsteopathicLine College of Dermatology Summer/Fall 2016 Vol. 32, No. 2 Message from the President Greetings from Texas! Before I begin, let us pause and remember the lives of the fallen police officers in grief-stricken Dallas, victims of the tragic event in Nice and the deaths of innocent people around the world. As President of the AOCD, I welcome you to this edition of DermLine. I must extend my special thanks to Dr. Rick Lin, our Immediate Past President, who has supported me tirelessly during this term. His friendship and his willingness to share his knowledge have proven invaluable. I also would like to acknowledge the Board of Trustees, Marsha Wise and the entire AOCD team – your support of me has been tireless and humbling. While writing this brief missive, I am preparing for a trip to Chicago to attend the annual AOA House of Delegates meeting. I am reminded of the great progress we have made in moving the AOCD forward! A single accreditation system for graduate medical education programs in the United States marks a true milestone in the lives of graduates of osteopathic institutions. Our doctors will now complete their residency and/or fellowship education in ACGME-accredited programs and demonstrate achievement of common milestones and competencies without impediments. It is my hope that osteopathic and allopathic graduates who train together, side by side, will no longer be a divided group. Our work is not done! As I mentioned in my last message, the AOCD remains a strong organization. I am proud of our heritage and mindful of the work that lies ahead.
    [Show full text]